Related Experiment Videos

Recovery of cardiac function with total transapical left ventricular bypass

Transactions - American Society for Artificial Internal Organs
|January 1, 1980
PubMed

Insights

Transapical left ventricular assist device (TALVB) supports patients with severe cardiac failure by unloading the left ventricle. Two of six patients recovered sufficient heart function to remove the device, demonstrating its potential for temporary circulatory support.

Area of Science:

  • Cardiovascular Surgery
  • Mechanical Circulatory Support
  • Cardiac Physiology

Background:

  • Severe cardiac failure presents a critical challenge in managing patients with end-stage heart disease.
  • Mechanical circulatory support devices offer a potential solution for patients awaiting recovery or transplantation.
  • Transapical left ventricular bypass (TALVB) is an advanced technique for direct cardiac unloading.

Observation:

  • The study applied transapical left ventricular bypass (TALVB) in six patients experiencing critical cardiac failure.
  • All patients required total TALVB, with the aortic valve closed, for circulatory support.
  • Support durations ranged from one to 144 hours.

Findings:

  • Two out of six patients demonstrated recovery of life-sustaining myocardial function, enabling TALVB system removal.
  • One patient achieved complete recovery without additional organ dysfunction.
  • Continuous decompression and unloading of the left ventricle by TALVB maintained circulation in dire situations.

Implications:

  • TALVB effectively decompresses and unloads the left ventricle during both systole and diastole.
  • This method can sustain circulation in patients with otherwise terminal cardiac conditions.
  • Successful TALVB application suggests potential for myocardial recovery and device explantation in select cases.

Related Concept Videos